List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 26 studies with search of:   "Vindesine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide
Condition: Small Cell Lung Carcinoma
Intervention: Drug: Adriamycin, cyclophosphamide, vindesine, valproic acid
2 Completed A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Cisplatin+Vindesine+MMC/ concurrent radiation;   Drug: Irinotecan+Carboplatin/concurrent radiation;   Drug: Paclitaxel+Carboplatin/concurrent radiation
3 Completed Trial of Pre-Operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)
Condition: Pulmonary Neoplasm
Intervention: Drug: mitomycin C, vindesine, cisplatin and radiotherapy
4 Active, not recruiting Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: mesna;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: low-LET cobalt-60 gamma ray therapy;   Procedure: low-LET electron therapy;   Procedure: low-LET photon therapy;   Procedure: radioisotope therapy
5 Recruiting Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Condition: Adult Acute Lymphocytic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Dexamethasone / Prednisolone;   Drug: Vincristine;   Drug: Daunorubicin;   Drug: Asparaginase;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Mercaptopurine;   Drug: G-CSF;   Drug: Vindesine;   Drug: VP16;   Drug: Adriamycin;   Drug: Thioguanine;   Drug: VM26;   Drug: Rituximab;   Procedure: CNS irradiation;   Procedure: Mediastinal irradiation (if residual TU);   Procedure: Stem cell transplantation
6 Recruiting Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine
7 Recruiting Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: carboplatin;   Drug: carmustine;   Drug: cyclosporine;   Drug: cytarabine;   Drug: dexamethasone;   Drug: etoposide phosphate;   Drug: idarubicin;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: lomustine;   Drug: melphalan;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: prednisolone;   Drug: thiotepa;   Drug: vinblastine;   Drug: vindesine;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: total-body irradiation
8 Active, not recruiting Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: bleomycin;   Drug: cisplatin;   Drug: fluorouracil;   Drug: ifosfamide;   Drug: methotrexate;   Drug: mitomycin C;   Drug: vinblastine;   Drug: vindesine;   Procedure: radiation therapy
9 Recruiting German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults
Condition: Lymphoma, Lymphoblastic
Interventions: Drug: Dexamethasone/Prednisolone;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Daunorubicin;   Drug: Asparaginase;   Drug: G-CSF;   Drug: Mercaptopurine;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: VP16;   Drug: Vindesine;   Drug: Adriamycin;   Drug: Thioguanine;   Drug: HDARAC;   Procedure: CNS irradiation;   Procedure: Mediastinal irradiation;   Drug: Cladribine
10 Recruiting Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: radiation therapy
11 Recruiting Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: filgrastim;   Drug: ifosfamide;   Drug: iodine I 131 metaiodobenzylguanidine;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: radiation therapy
12 Active, not recruiting Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: vinblastine;   Drug: vindesine;   Drug: vinorelbine ditartrate;   Procedure: radiation therapy
13 Active, not recruiting Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: ifosfamide;   Drug: melphalan;   Drug: tretinoin;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
14 Recruiting Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: mitoxantrone hydrochloride;   Drug: prednisolone;   Drug: therapeutic hydrocortisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
15 Active, not recruiting Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: prednisolone;   Drug: teniposide;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
16 Recruiting Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: filgrastim;   Drug: ifosfamide;   Drug: iodine I 131 metaiodobenzylguanidine;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
17 Active, not recruiting Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: filgrastim;   Drug: idarubicin;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: prednisolone;   Drug: vindesine
18 Active, not recruiting Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: ifosfamide;   Drug: mitomycin C;   Drug: vinblastine;   Drug: vindesine;   Drug: vinorelbine ditartrate;   Procedure: conventional surgery;   Procedure: radiation therapy
19 Recruiting Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bleomycin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: filgrastim;   Drug: ifosfamide;   Drug: methotrexate;   Drug: prednisolone;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate;   Drug: vindesine
20 Completed Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: dexamethasone;   Drug: asparaginase;   Drug: Asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin;   Drug: doxorubicin;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: mercaptopurine;   Drug: Methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: Vincristine;   Drug: Vindesine

Previous Page Studies Shown (1-20) Next (21-26)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services